Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Published

Journal Article (Review)

Full Text

Duke Authors

Cited Authors

  • Granger, CB; Armaganijan, LV

Published Date

  • January 3, 2012

Published In

Volume / Issue

  • 125 / 1

Start / End Page

  • 159 - 164

PubMed ID

  • 22215890

Pubmed Central ID

  • 22215890

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.111.031146

Language

  • eng

Conference Location

  • United States